UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000004824
Receipt No. R000005740
Official scientific title of the study Development of clinical Magnetic Resonance Imaging techniques using high field magnetic resonance
Date of disclosure of the study information 2011/02/01
Last modified on 2016/07/15 (Ver. 13)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Development of clinical Magnetic Resonance Imaging techniques using high field magnetic resonance
Title of the study (Brief title) Clinical MRI technique development
Region
Japan

Condition
Condition liver cirrhosis
gynecological diseases
myopia
donor of liver transplantation
Hypertension
Classification by specialty
Medicine in general Hepato-biliary-pancreatic medicine Cardiology
Pneumology Hepato-biliary-pancreatic surgery Obsterics and gynecology
Ophthalmology Radiology Neurosurgery
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Our first object is to adjust 3T MR machine located for only research that was developed at NEDO project, for clinical usage.
Secondly, providing highly advanced examination for the patients is important object by establishing the new MR taking sequences.
Basic objectives2 Others
Basic objectives -Others Detection of image changes related to pathophysiology.
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Investigation of diagnostic capability of a new acquisition method
Key secondary outcomes Evalulation of image quality and artifacts of a new acquisition method

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -but assessor(s) are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Diagnosis
Type of intervention
Device,equipment Other
Interventions/Control_1 taking MR imaging
Interventions/Control_2 taking MR imaging
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria patients who agreed to takiing MR images
Key exclusion criteria Contraindication of MRI scan
Poor image quality
Target sample size 480

Research contact person
Name of lead principal investigator Kaori Togashi
Organization Kyoto university
Division name diagnostic radiology and nuclear medicine
Address 57ShogoinKawahara-cho, Sakyo, Kyoto city, Kyoto
TEL 075-751-3760
Email ktogashi@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Aki KIDO
Organization Kyoto university
Division name diagnostic radiology and nuclear medicine
Address 57ShogoinKawahara-cho, Sakyo, Kyoto city, Kyoto
TEL 075-751-3760
Homepage URL
Email akikido@kuhp.kyoto-u.ac.jp

Sponsor
Institute Kyoto university
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Toshiba medical Systems Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization japan

Other related organizations
Co-sponsor Toshiba medical Systems Corporation
Name of secondary funder(s) no

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 京都大学医学部附属病院(京都府)

Other administrative information
Date of disclosure of the study information
2011 Year 02 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 01 Month 05 Day
Anticipated trial start date
2011 Year 02 Month 01 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
2016 Year 03 Month 31 Day
Date trial data considered complete
2016 Year 03 Month 31 Day
Date analysis concluded
2016 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results Comparison of non-contrast enhanced brain angiography between FSBB and TOF
Other related information

Management information
Registered date
2011 Year 01 Month 06 Day
Last modified on
2016 Year 07 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005740